Skip to content

Culturally Targeted & Individually Tailored Smoking Cessation Study: LGBT Smokers

A Culturally Targeted and Individually Tailored Smoking Cessation Intervention for LGBT Smokers

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01633567
Enrollment
400
Registered
2012-07-04
Start date
2012-05-31
Completion date
2016-01-31
Last updated
2017-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cigarette Smoking

Keywords

Smoking Cessation, Cigarette Smoking, Tobacco, LGBT, LGBTQ

Brief summary

For the approximately 4.6 million LGBT persons in the U.S., smoking rates among those living in urban areas are roughly twice that of heterosexuals. Targeted interventions have shown great promise in reducing health risk behaviors across a variety of behaviors and population groups by enhancing the relevance of the health information. The primary aim of this study is to test the efficacy of a culturally targeted group-based smoking cessation intervention (vs. a non-targeted intervention) on smoking outcomes among lesbian, gay, bisexual, and transgender (LGBT) smokers. The investigators anticipate that the culturally targeted intervention will be more effective at helping LGBT smokers to successfully stop smoking than will the non-targeted intervention.

Detailed description

In Phase 1 of this study we used focus groups to establish the cultural appropriateness and acceptability of the targeted elements of the intervention for the LGBT population. For Phase 2 of this study, we seek to enroll 400 participants in a randomized controlled trial of the targeted intervention vs. a non-targeted, comparison condition. Both conditions will consist of group counseling sessions combined with nicotine replacement therapy and peer support. We expect that quit rates, stage of readiness, perceived benefits, self-efficacy, and treatment adherence will be higher among those who received the targeted intervention than those in the non-targeted intervention. Furthermore, we expect that a stronger LGBT cultural identification and salience of that identity will be associated with more satisfaction and adherence to the targeted intervention.

Interventions

BEHAVIORALCulturally Targeted Cessation Program

The culturally targeted version of the behavioral counseling intervention will consist of six group-based smoking cessation counseling sessions. Each smoking cessation therapy session will last approximately 90 minutes and will begin two weeks before the quit date. In addition, participants will be provided nicotine replacement therapy and peer support sessions will occur between the group sessions.

BEHAVIORALNon-Targeted Cessation Program

Behavioral counseling intervention will consist of six group-based smoking cessation counseling sessions. Each smoking cessation therapy session will last approximately 90 minutes and will begin two weeks before the quit date. In addition, participants will be provided nicotine replacement therapy and peer support sessions will occur between the group sessions.

Sponsors

National Institute on Drug Abuse (NIDA)
CollaboratorNIH
National Cancer Institute (NCI)
CollaboratorNIH
Howard Brown Health Center
CollaboratorOTHER
University of Illinois at Chicago
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Self identify as lesbian, gay, bisexual, or transgender * Age 18-65 * Current cigarette smoker * Desire to quit smoking (self-report rating of interest in quitting) * Relatively healthy, with no medical conditions that would adversely interact with study parameters (see

Exclusion criteria

for specific details) * Agree to attend behavioral counseling sessions, be randomized, and be followed-up * Agrees to use nicotine patch and has no prior adverse reactions to patch * Has stable residence and telephone and can provide the name of an outside household collateral family member or close friend for contact and follow-up.

Design outcomes

Primary

MeasureTime frameDescription
7-Day Point Prevalence Smoking Quit Rates 1 Month Post Quit DateAssessed 1 month after quit date7-Day point prevalence smoking quit rates will serve as the main outcome measure and will be obtained from Time Line Follow-Back (TLFB) interviews.
7-Day Point Prevalence Smoking Quit Rates 3 Months Post Quit DateAssessed 3 months after quit date7-Day point prevalence smoking quit rates will serve as the main outcome measure and will be obtained from Time Line Follow-Back (TLFB) interviews.
7-Day Point Prevalence Smoking Quit Rates 6 Months Post Quit DateAssessed 6 months after quit date7-Day point prevalence smoking quit rates will serve as the main outcome measure and will be obtained from Time Line Follow-Back (TLFB) interviews.
7-Day Point Prevalence Smoking Quit Rates 12 Months Post Quit DateAssessed 12 months after quit date7-Day point prevalence smoking quit rates will serve as the main outcome measure and will be obtained from Time Line Follow-Back (TLFB) interviews.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 20, 2026